Literature DB >> 22803822

The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.

Sónia Silva1, Priscila Pires, Douglas R Monteiro, Melyssa Negri, Luiz F Gorup, Emerson R Camargo, Débora B Barbosa, Rosário Oliveira, David W Williams, Mariana Henriques, Joana Azeredo.   

Abstract

The aim of this study was to compare biofilm formation by Candida glabrata and Candida albicans on acrylic, either individually or when combined (single and dual species) and then examine the antimicrobial effects of silver nanoparticles and nystatin on these biofilms. Candidal adhesion and biofilm assays were performed on acrylic surface in the presence of artificial saliva (AS) for 2 h and 48 h, respectively. Candida glabrata and C. albicans adherence was determined by the number of colony forming units (CFUs) recovered from the biofilms on CHROMagar(®) Candida. In addition, crystal violet (CV) staining was used as an indicator of biofilm biomass and to quantify biofilm formation ability. Pre-formed biofilms were treated either with silver nanoparticles or nystatin and the effect of these agents on the biofilms was evaluated after 24 h. Results showed that both species adhered to and formed biofilms on acrylic surfaces. A significantly (P < 0.05) higher number of CFUs was evident in C. glabrata biofilms compared with those formed by C. albicans. Comparing single and dual species biofilms, equivalent CFU numbers were evident for the individual species. Both silver nanoparticles and nystatin reduced biofilm biomass and the CFUs of single and dual species biofilms (P < 0.05). Silver nanoparticles had a significantly (P < 0.05) greater effect on reducing C. glabrata biofilm biomass compared with C. albicans. Similarly, nystatin was more effective in reducing the number of CFUs of dual species biofilms compared with those of single species (P < 0.05). In summary, C. glabrata and C. albicans can co-exist in biofilms without apparent antagonism, and both silver nanoparticles and nystatin exhibit inhibitory effects on biofilms of these species.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22803822     DOI: 10.3109/13693786.2012.700492

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  17 in total

1.  From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms.

Authors:  Christopher G Pierce; Anand Srinivasan; Anand K Ramasubramanian; José L López-Ribot
Journal:  Microbiol Spectr       Date:  2015-06

2.  Inhibition of Candida albicans biofilm by pure selenium nanoparticles synthesized by pulsed laser ablation in liquids.

Authors:  Grégory Guisbiers; Humberto H Lara; Ruben Mendoza-Cruz; Guillermo Naranjo; Brandy A Vincent; Xomalin G Peralta; Kelly L Nash
Journal:  Nanomedicine       Date:  2016-10-25       Impact factor: 5.307

Review 3.  New perspectives on the topical management of recurrent candidiasis.

Authors:  Ana Carolina S Ré; Jayanaraian F Martins; Marcílio Cunha-Filho; Guilherme M Gelfuso; Carolina P Aires; Taís Gratieri
Journal:  Drug Deliv Transl Res       Date:  2021-01-19       Impact factor: 4.617

4.  Competitive Interactions between C. albicans, C. glabrata and C. krusei during Biofilm Formation and Development of Experimental Candidiasis.

Authors:  Rodnei Dennis Rossoni; Júnia Oliveira Barbosa; Simone Furgeri Godinho Vilela; Jéssica Diane dos Santos; Patrícia Pimentel de Barros; Márcia Cristina de Azevedo Prata; Ana Lia Anbinder; Beth Burgwyn Fuchs; Antonio Olavo Cardoso Jorge; Eleftherios Mylonakis; Juliana Campos Junqueira
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

5.  Easy on-demand single-pass self-assembly and modification to fabricate gold@graphene-based anti-inflammatory nanoplatforms.

Authors:  Jeong Hoon Byeon; Jae Hong Park
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

6.  Relationship between Pyruvate Kinase Activity and Cariogenic Biofilm Formation in Streptococcus mutans Biotypes in Caries Patients.

Authors:  Wirginia Krzyściak; Monika Papież; Anna Jurczak; Dorota Kościelniak; Palina Vyhouskaya; Katarzyna Zagórska-Świeży; Anna Skalniak
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

7.  Ag(I) camphorimine complexes with antimicrobial activity towards clinically important bacteria and species of the Candida genus.

Authors:  João M S Cardoso; Soraia I Guerreiro; Andreia Lourenço; Marta M Alves; M Fátima Montemor; Nuno P Mira; Jorge H Leitão; M Fernanda N N Carvalho
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

Review 8.  Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?

Authors:  Aline Raquel Voltan; Guillermo Quindós; Kaila P Medina Alarcón; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2016-08-08

Review 9.  Candida glabrata Biofilms: How Far Have We Come?

Authors:  Célia F Rodrigues; Maria Elisa Rodrigues; Sónia Silva; Mariana Henriques
Journal:  J Fungi (Basel)       Date:  2017-03-01

10.  Biogenic nanosilver synthesized in Metarhizium robertsii waste mycelium extract - As a modulator of Candida albicans morphogenesis, membrane lipidome and biofilm.

Authors:  Barbara Różalska; Beata Sadowska; Aleksandra Budzyńska; Przemysław Bernat; Sylwia Różalska
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.